News
Sunscreen ingredients found in bloodstream, but health impact unknown
“All four sunscreen active ingredients tested resulted in exposures exceeding 0.5 ng/mL.”
Opinion
The 39th ASLMS meeting is now underway
WASHINGTON – The current and past presidents of the American Society for Laser Medicine and Surgery recently sat down to discuss the Society’s...
Video
Acne take home messages from the AAD annual meeting
WASHINGTON – “We want to treat sooner, and we want to prevent scarring.”
Video
VIDEO: Immunomodulators for inflammatory skin diseases
WASHINGTON - Off-label therapies discussed by Dr. Friedman include dapsone, hydroxychloroquine, and pentoxifylline.
Video
Immunomodulators for pediatric skin diseases
WASHINGTON – Pediatric dermatologist A. Yasmine Kirkorian, MD, provides clinical pearls and practical considerations on the use of...
Video
Food allergies and atopic dermatitis: What is the evidence?
WASHINGTON – Many patients believe that food allergy is what is driving their eczema, “and that’s the part we don’t really think bears out” in...
Video
SPD president discusses pediatric research, and more
WASHINGTON – The SPD now has more than 1,200 members and a research arm, the Pediatric Dermatology Research Alliance (PeDRA)...
News
FDA approves new treatment for hereditary transthyretin-mediated amyloidosis
Inotersen inhibits the production of amyloid in patients with the rare disorder.
News
FDA expands approval of 9-valent HPV vaccine
Gardasil-9 is now approved for men and women aged 27-45 years.
News
Bertilimumab granted orphan drug status for bullous pemphigoid
A pivotal phase 2/3 trial of bertilimumab will begin next year, according to the company.
Video
Climbing the therapeutic ladder in eczema-related itch
WASHINGTON – Oral medications include antihistamines, followed by “more intense”...
Video
CUBE-C initiative aims to educate about atopic dermatitis
WASHINGTON – “The hope is that programs like these pop up all over the place.”
News
SPOTme addresses unmet need for skin cancer screening
Of those who were clinically diagnosed with melanoma during 1992-2010, 83% said they did not have a regular dermatologist.
News
FDA approves rituximab for treating pemphigus vulgaris
Approval was based on a prospective, multicenter, open-label, randomized study conducted in France.
News
National Rosacea Society designates April as “Rosacea Awareness Month”
The NRS estimates that 16 million people in the United States have rosacea, which also affects the eyes in about half of patients.